Form 4: Aehr Test Systems Director Howard Slayen Receives Equity Grant of 9,253 Restricted Stock Units

Aehr Test Systems Director Howard T. Slayen was granted 9,253 shares of common stock in the form of restricted stock units, vesting quarterly over two years, as reported in a recent SEC Form 4 filing.

Summary

• Howard T. Slayen, a Director of Aehr Test Systems (AEHR), acquired 9,253 shares of common stock on July 2, 2025.
• The acquisition was a grant at a price of $0 per share, indicating restricted stock units (RSUs).
• These RSUs will vest at a rate of one-eighth (1/8) of the total shares every three full calendar months, contingent on Slayen's continued service as a Board member.
• Following this transaction, Howard T. Slayen's total beneficial ownership in Aehr Test Systems is 229,967 shares, which includes unvested restricted stock units.

Sentiment

Score: 7

Explanation: The document reports a routine equity grant to a director, which is a positive for aligning interests and retaining talent, but does not contain information that would significantly alter the company's financial outlook or operations.

Positives

• The grant of restricted stock units aligns the director's interests with long-term shareholder value.
• The vesting schedule encourages continued board service and commitment from the director.

Future Outlook

The vesting schedule for the restricted stock units indicates a future commitment from Director Howard T. Slayen to continue serving on the Board of Directors, with vesting occurring quarterly over a two-year period.

Industry Context

This transaction represents a standard form of equity compensation for board members in publicly traded companies, aiming to align their long-term interests with company performance and shareholder returns within the semiconductor test equipment industry.

Comparison to Industry Standards

• Equity grants, particularly Restricted Stock Units (RSUs), are a common compensation practice for non-employee directors across various industries, including technology and semiconductor sectors.
• The vesting schedule of 1/8th quarterly over two years is a typical structure designed to retain directors and incentivize long-term commitment, comparable to practices at companies like Teradyne (TER) or Cohu (COHU) in the semiconductor test space, which also utilize equity-based compensation for their board members.

Corporate Governance

Stakeholder Impact

• Shareholders: The grant of RSUs to a director aligns the director's interests with shareholder value creation, as the value of the compensation is tied to the company's stock performance.

Next Steps

• Continued vesting of 1/8th of the granted restricted stock units every three full calendar months, contingent on Howard T. Slayen's continued service as a Board member.

Key Dates

Recommendation

Keywords

Aehr Test Systems, AEHR, Howard T. Slayen, Form 4, Restricted Stock Units, RSU, Director Compensation, Equity Grant, Insider Transaction, Beneficial Ownership